scispace - formally typeset
D

Didier Dreyfuss

Researcher at Paris Diderot University

Publications -  44
Citations -  1653

Didier Dreyfuss is an academic researcher from Paris Diderot University. The author has contributed to research in topics: Acute kidney injury & Renal replacement therapy. The author has an hindex of 12, co-authored 44 publications receiving 1170 citations. Previous affiliations of Didier Dreyfuss include Sorbonne & French Institute of Health and Medical Research.

Papers
More filters
Journal ArticleDOI

Beneficial effects of humidified high flow nasal oxygen in critical care patients: a prospective pilot study

TL;DR: HFNC has a beneficial effect on clinical signs and oxygenation in ICU patients with acute respiratory failure, and favorable results constitute a prerequisite to launching a randomized controlled study to investigate whether HFNC reduces intubation in these patients.
Journal ArticleDOI

Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury.

TL;DR: Among critically ill patients with acute kidney injury, an accelerated renal-replacement strategy was not associated with a lower risk of death at 90 days than a standard strategy, and the most effective timing for the initiation of such therapy remains uncertain.
Journal ArticleDOI

Impact of high-flow nasal cannula oxygen therapy on intensive care unit patients with acute respiratory failure: A prospective observational study ☆ ☆☆

TL;DR: Use of HFNC in patients with persistent ARF was associated with significant and sustained improvement of both clinical and biologic parameters.
Journal ArticleDOI

Erratum to: 36th International Symposium on Intensive Care and Emergency Medicine: Brussels, Belgium. 15-18 March 2016

Ryon M. Bateman, +1875 more
- 20 Apr 2016 - 
TL;DR: This research presents a novel probabilistic procedure called “spot-spot analysis” that allows for real-time analysis of the response of the immune system to natural disasters.
Journal ArticleDOI

Humidified High Flow Nasal Oxygen During Respiratory Failure in the Emergency Department: Feasibility and Efficacy

TL;DR: HFNC is possible in the ED, and it alleviated dyspnea and improved respiratory parameters in subjects with acute hypoxemic respiratory failure, as compared to conventional oxygen therapy.